Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 September 1996

Effect of permanent ventricular pacing on ventricular repolarisation on ECG

Jarosław Kaźmierczak, Robert Gil, Krzysztof Przybycień, Marek Kisły, Zdzisława Kornacewicz-Jach

Med Sci Monit 1996; 2(5): CR558-563 :: ID: 500050


In 24 patients (14 males and 10 females, mean age 60±14) we assessed the effect of permanent ventricular pacing on ventricular repolarisation traced on ECG. We studied ventricular repolarisation abnormalities (VRA) such as changes in ST segment, T wave, corrected QT interval (QTc), QT dispersion (QTd) and the width of QRS complex of cardiotopic stimulations. VRA were classified into 6 categories. The measurements were taken prior to permanent pacemaker placement and 48 hours, 7, 14, 28 days and 12 months after insertion. The mean QTc, QTd and the width of QRS did not change significantly throughout the study. Ventricular repolarisation abnormalities first appeared 48 hours after pacemaker implantation to increase on 7-14 day and persist till day 26 when it was possible in 10 out of 24 patients to make the desired changes in programmable parameters (lowering the amplitude or changing the duration of impulse. Among the 10 patients whose pacemakers were reprogrammed we observed decreased VRA in 9 patients, while in 1 patient VRA did not change. Among the remaining 14 patients VRA decreased in 2, did not change in 10 and increased in 1 patient. Conclusions: 1. VRA of cardiotopic stimulations in patients with ventricular pacemakers are correlated with amplitude and with the stimulating impulse duration and tend to decrease when these parameters are lowered. 2. Permanent ventricular pacing changes the ECG of ventricular repolarisation of cardiotopic stimulations. It does not, however, increases the diversity of repolarisation assessed by QT dispersion.

Keywords: permanent pacing, ventricular repolarisation abnormalities (VRA), QT interval

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

17 Mar 2024 : Clinical Research  

Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942667  


27 Mar 2024 : Clinical Research  

Impact of Patient Education Formats on Treatment Adherence and Denture Hygiene in Edentulous Patients: A Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944175  

27 Mar 2024 : Clinical Research  

Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pa...

Med Sci Monit In Press; DOI: 10.12659/MSM.944114  

15 May 2024 : Database Analysis  

MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB

Med Sci Monit In Press; DOI: 10.12659/MSM.944685  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750